- Presentations
- 3
- Markets
- 1
Wezlana is a brand of Ustekinumab marketed by Nuvaila, with 3 presentations listed and registered in United States. Each presentation below has its own page with packs, documents and availability for export supply from India.
- Active ingredient (INN)
- Ustekinumab
- Brand owner
- Nuvaila
- Registered in
- United States
- Strengths and forms
- 130 mg/26 mL injection, 45 mg/0.5 mL injection, 90 mg/1 mL injection
All presentations
| Medicine | Manufacturer | Register | Availability |
|---|---|---|---|
| Wezlana 130 mg/26 mL injectionIntravenous Cold chain | Nuvaila | US FDA | Available on request |
| Wezlana 45 mg/0.5 mL injectionSubcutaneous Cold chain | Nuvaila | US FDA | Available on request |
| Wezlana 90 mg/1 mL injectionSubcutaneous Cold chain | Nuvaila | US FDA | Available on request |
Equivalent brands
Other brands of Ustekinumab.
Brand names and trademarks belong to their owners and are used only to identify products.
Request Wezlana
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.